Testing kidney protection with a combination of blood pressure and cholesterol drugs
Part of Heart & circulation clinical trials.
This trial is for people with high blood pressure and high cholesterol. It checks whether taking a combination of blood pressure medicine (fimasartan) with cholesterol medicines (atorvastatin and ezetimibe) can protect the kidneys better than just the first two drugs alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have high blood pressure (essential hypertension) and high cholesterol (primary hypercholesterolemia)
- You are planning to start treatment with fimasartan plus atorvastatin, or with fimasartan plus atorvastatin plus ezetimibe
- You have not taken the combination of fimasartan and atorvastatin together in the last 4 weeks
- You are not allergic to fimasartan, atorvastatin, or ezetimibe
- You have not taken any other experimental drug in the last 12 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single pill that combines two cholesterol-lowering medicines (pitavastatin and ezetimibe). It may be a good fit if you already take a statin or a statin plus ezetimibe and your doctor wants to adjust your treatment.
This trial tests a new combination blood pressure medicine called CKD-202A. It is for adults with high blood pressure who have not had other treatments or conditions that could affect the results.
This trial tests whether taking two experimental drugs together can safely lower both high blood pressure and high cholesterol. It may be an option if you have both conditions and your blood pressure is not extremely high.
This trial tests whether taking a moderate-strength statin (cholesterol-lowering drug) plus ezetimibe (another cholesterol medicine) together helps protect the heart and kidneys in people who have both chronic kidney disease and established heart disease or stroke history.
This trial studies whether fixed-dose blood pressure medicines—either two drugs (fimasartan + amlodipine) or three drugs (fimasartan + amlodipine + hydrochlorothiazide)—work well and are safe. It may help your care team compare how these combinations control blood pressure and what side effects occur.
This trial tests if a new treatment combination (finerenone plus a water pill) works better than a standard fixed-dose combination for people with both high blood pressure and chronic kidney disease. It aims to find which option provides more clinical benefit.
Hear when a new Essential Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.